CIK 0000873303
- Large accelerated filer
Sarepta Therapeutics, Inc.
Sign in to watch- Ticker
- SRPT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 930797222
- Phone
- +1 617-274-4000
- Business address
- 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-06-07 | O'Neill Gilmore Neil SVP & Chief Medical Officer | Grant or award · Stock option (right to buy) | +100,000 | 100,000 | ||
| 2018-06-07 | O'Neill Gilmore Neil SVP & Chief Medical Officer | Grant or award · Restricted Stock Units | +12,000 | 12,000 | ||
| 2018-05-22 | Ruff Shamim SVP, Chief Regulatory Affairs | Exercise or conversion | +4,432 | 33,241 | ||
| 2018-05-22 | Ruff Shamim SVP, Chief Regulatory Affairs | Shares withheld for taxes | −1,305 | $89.22 | $116K | 31,936 |
| 2018-05-22 | Ruff Shamim SVP, Chief Regulatory Affairs | Exercise or conversion · Restricted Stock Units | −4,432 | 0 | ||
| 2018-05-22 | Mahatme Sandesh EVP, CFO & CBO | Exercise or conversion | +6,649 | 49,310 | ||
| 2018-05-22 | Mahatme Sandesh EVP, CFO & CBO | Shares withheld for taxes | −2,024 | $89.22 | $181K | 47,286 |
| 2018-05-22 | Mahatme Sandesh EVP, CFO & CBO | Exercise or conversion · Restricted Stock Units | −6,649 | 0 | ||
| 2018-05-22 | Howton David T SVP, General Counsel | Exercise or conversion | +5,319 | 36,437 | ||
| 2018-05-22 | Howton David T SVP, General Counsel | Shares withheld for taxes | −1,566 | $89.22 | $140K | 34,871 |
| 2018-05-22 | Howton David T SVP, General Counsel | Exercise or conversion · Restricted Stock Units | −5,319 | 0 | ||
| 2018-05-22 | Cumbo Alexander SVP, Chief Commercial Officer | Exercise or conversion | +4,876 | 30,201 | ||
| 2018-05-22 | Cumbo Alexander SVP, Chief Commercial Officer | Shares withheld for taxes | −1,435 | $89.22 | $128K | 28,766 |
| 2018-05-22 | Cumbo Alexander SVP, Chief Commercial Officer | Exercise or conversion · Restricted Stock Units | −4,876 | 0 | ||
| 2018-03-15 | Ruff Shamim SVP, Chief Regulatory Affairs | Exercise or conversion | +469 | $13.90 | $7K | 27,514 |
| 2018-03-15 | Ruff Shamim SVP, Chief Regulatory Affairs | Shares withheld for taxes | −80 | $81.22 | $6K | 27,434 |
| 2018-03-15 | Ruff Shamim SVP, Chief Regulatory Affairs | Exercise or conversion | +2,031 | $26.24 | $53K | 29,465 |
| 2018-03-15 | Ruff Shamim SVP, Chief Regulatory Affairs | Shares withheld for taxes | −656 | $81.22 | $53K | 28,809 |
| 2018-03-15 | Ruff Shamim SVP, Chief Regulatory Affairs | Exercise or conversion · Stock option (right to buy) | −469 | 6,134 | ||
| 2018-03-15 | Ruff Shamim SVP, Chief Regulatory Affairs | Exercise or conversion · Stock option (right to buy) | −2,031 | 10,066 |
Page 35 of 38 · 760 trades